GASTROESOPHAGEAL ADENOCARCINOMA
Clinical trials for GASTROESOPHAGEAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial tests new drug combo against aggressive stomach cancers
Disease control OngoingThis large Phase 3 study is testing whether a new drug combination works better than the current standard treatment for advanced HER2-positive stomach and esophageal cancers that cannot be removed by surgery. The trial will involve 920 patients and compares zanidatamab plus chemo…
Matched conditions: GASTROESOPHAGEAL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for tough cancers: first test of experimental drug begins
Disease control OngoingThis is the first study in people to test the safety and early effectiveness of an investigational drug called ABBV-400 for adults with advanced solid tumors that have stopped responding to standard treatments. The study will find the best dose of ABBV-400 given alone and will al…
Matched conditions: GASTROESOPHAGEAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC